MICHAEL KACSMAR: Open Payments
NPI 1427282706 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,057 in 65 payments from 11 companies in 2025. Trend: 2023 $1,156 · 2024 $1,294 · 2025 $1,057
Food & beverage: $1,057
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $230 |
| Alnylam Pharmaceuticals Inc. | 3 | $171 |
| Novo Nordisk Inc | 6 | $166 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $118 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 36 | $105 |
| Merck Sharp & Dohme LLC | 5 | $100 |
| Novartis Pharmaceuticals Corporation | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| MEDICOMP INC | 2 | $33 |
| TOLMAR, INC. | 1 | $21 |
Products named: Wegovy, AMVUTTRA, VYNDAQEL, CAPLYTA, LifeVest, VERQUVO, NURTEC ODT, JARDIANCE.
Industry payments across PA — which companies pay providers there.
